Video

Anat Loewenstein Talks ForeSeeHome, Unmet Needs in Retinal Disease

Author(s):

The biggest unmet need nowadays in retina disease is geographic atrophy..."

In the second installment of MD Magazine’s sitdown with Tel Aviv Medical Center Ophthalmology Department Chair Anat Loewenstein, she spoke of needs to be addressed in the treatment of patients with retina diseases as well as other projects she is involved in.

“I think the biggest unmet need nowadays in retina disease is geographic atrophy and the need for frequent treatment and monitoring,” she said.

“I’m involved in many research projects, and I think the most exciting ones have to do with monitoring of the disease and with automated detection of choroidal neovascular activity,” Loewenstein said, before discussing ForeSeeHome, the home-based age-related macular degeneration monitoring device that she expects to be adopted worldwide in the coming years.

Related Videos
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Gaith Noaiseh, MD: Nipocalimab Improves Disease Measures, Reduces Autoantibodies in Sjogren’s
A. Sidney Barritt, MD | Credit: UNC School of Medicine
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
© 2024 MJH Life Sciences

All rights reserved.